Spearhead Capital Advisors, LLC Amgen Inc Transaction History

Spearhead Capital Advisors, LLC

$92.3 Million
Q3 2022

A detailed history of Spearhead Capital Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Spearhead Capital Advisors, LLC holds 4,417 shares of AMGN stock, worth $1.24 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares

4,417

Previous 37,894 88.34%

Holding current value

$1.24 Million

Previous $9.22 Million 89.2%

% of portfolio

1.08%

Previous 1.38%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$224.46 - $253.15 $7.51 Million - $8.47 Million	-33,477 Reduced 88.34%	4,417 $996,000
Q2 2022 Aug 10, 2022	SELL	$230.71 - $256.74 $1.81 Million - $2.01 Million	-7,833 Reduced 17.13%	37,894 $9.22 Million
Q1 2022 Apr 28, 2022	BUY	$219.27 - $242.57 $551,244 - $609,820	2,514 Added 5.82%	45,727 $11.1 Million
Q4 2021 Jan 25, 2022	BUY	$198.88 - $227.6 $246,213 - $281,768	1,238 Added 2.95%	43,213 $9.72 Million
Q3 2021 Oct 27, 2021	BUY	$212.27 - $248.7 $1.31 Million - $1.53 Million	6,160 Added 17.2%	41,975 $8.93 Million
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $145,053 - $160,925	621 Added 1.76%	35,815 $8.73 Million
Q1 2021 Apr 28, 2021	BUY	$221.91 - $258.6 $1.82 Million - $2.12 Million	8,212 Added 30.44%	35,194 $8.76 Million
Q4 2020 Feb 02, 2021	BUY	$216.38 - $257.67 $174,835 - $208,197	808 Added 3.09%	26,982 $6.2 Million
Q3 2020 Oct 16, 2020	BUY	$234.65 - $260.95 $465,780 - $517,985	1,985 Added 8.21%	26,174 $6.65 Million
Q2 2020 Jul 16, 2020	SELL	$197.81 - $242.74 $148,357 - $182,055	-750 Reduced 3.01%	24,189 $5.71 Million
Q1 2020 Apr 17, 2020	BUY	$182.24 - $241.7 $403,661 - $535,365	2,215 Added 9.75%	24,939 $5.06 Million
Q4 2019 Feb 06, 2020	BUY	$189.21 - $243.2 $232,160 - $298,406	1,227 Added 5.71%	22,724 $5.48 Million
Q3 2019 Oct 21, 2019	BUY	$174.11 - $208.62 $3,482 - $4,172	20 Added 0.09%	21,497 $4.16 Million
Q2 2019 Jul 17, 2019	BUY	$166.7 - $195.41 $298,059 - $349,393	1,788 Added 9.08%	21,477 $3.96 Million
Q1 2019 Apr 23, 2019	BUY	$180.87 - $203.88 $142,525 - $160,657	788 Added 4.17%	19,689 $3.74 Million
Q4 2018 Feb 07, 2019	SELL	$178.4 - $208.25 $77,604 - $90,588	-435 Reduced 2.25%	18,901 $3.68 Million
Q3 2018 Oct 11, 2018	BUY	$185.29 - $208.89 $54,660 - $61,622	295 Added 1.55%	19,336 $3.98 Million
Q2 2018 Jul 25, 2018	BUY	$166.05 - $186.51 $183,983 - $206,653	1,108 Added 6.18%	19,041 $3.52 Million
Q1 2018 Apr 12, 2018	BUY	$169.43 - $198.0 $2.03 Million - $2.37 Million	11,994 Added 201.95%	17,933 $3.06 Million
Q4 2017 Jan 23, 2018	BUY	$168.79 - $188.59 $1 Million - $1.12 Million	5,939	5,939 $1.03 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.

Account

Spearhead Capital Advisors, LLC Amgen Inc Transaction History